Biphasic ferrogels for triggered drug and cell delivery

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Ferrogels are promising for on-demand drug delivery in biomedical applications.
• Current ferrogels have limitations in harboring and releasing viable cells, especially at small scales.
• Monophasic ferrogels exhibit reduced deformation in small devices, hindering therapeutic efficacy.

Purpose of the Study:

• To develop and characterize a novel biphasic ferrogel for enhanced cell-based therapies.
• To overcome the limitations of monophasic ferrogels in small implantable device dimensions.
• To enable on-demand release of both drugs and viable cells.

Main Methods:

• Fabrication of a biphasic ferrogel with an iron oxide gradient.
• Evaluation of material deformation under magnetic fields at various scales.
• Assessment of porosity, mechanical properties, and potential biocompatibility.

Main Results:

• The biphasic ferrogel achieves significant deformation and triggered release even at small dimensions (e.g., 2 mm thickness).
• Biphasic ferrogels exhibit increased porosity and enhanced mechanical properties compared to monophasic counterparts.
• Reduced iron oxide content suggests potentially improved biocompatibility.

Conclusions:

• Biphasic ferrogels represent a significant advancement for cell-based therapies and on-demand delivery systems.
• These materials are well-suited for applications in tissue engineering and regenerative medicine.
• The developed ferrogels offer a versatile platform for delivering therapeutic drugs and viable cells.